VIOLIN Logo
Virmugen Banner
Search: for Help
Virmugen Home
Introduction
Statistics
News and Updates
Virmugen Query
Virmugen Blast
Data Submission
Data Exchange
Data Download
Documentation
FAQs
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Comparison

Equid herpesvirus gE mutant vaccine Equid herpesvirus gI mutant vaccine Equid herpesvirus TK mutant vaccine
Vaccine Information Vaccine Information Vaccine Information
  • Vaccine Ontology ID: VO_0002955
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • gE gene engineering:
    • Type: Gene mutation
    • Description: This gE mutant is from Equid herpesvirus 1 (Tsujimura et al., 2006).
    • Detailed Gene Information: Click Here.
  • Immunization Route: intranasal immunization
  • Vaccine Ontology ID: VO_0002956
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • gI gene engineering:
    • Type: Gene mutation
    • Description: This gI mutant is from Equid herpesvirus 1 (Tsujimura et al., 2006).
    • Detailed Gene Information: Click Here.
  • Immunization Route: intranasal immunization
  • Product Name: PR1
  • Vaccine Ontology ID: VO_0002957
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse, horse
  • TK gene engineering:
    • Type: Gene mutation
    • Description: This TK mutant is from Equid herpesvirus 1 (Slater et al., 1993).
    • Detailed Gene Information: Click Here.
  • Immunization Route: intranasal immunization
References References References
Tsujimura et al., 2006: Tsujimura K, Yamanaka T, Kondo T, Fukushi H, Matsumura T. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. The Journal of veterinary medical science / the Japanese Society of Veterinary Science. 2006; 68(10); 1029-1038. [PubMed: 17085880].
Tsujimura et al., 2006: Tsujimura K, Yamanaka T, Kondo T, Fukushi H, Matsumura T. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. The Journal of veterinary medical science / the Japanese Society of Veterinary Science. 2006; 68(10); 1029-1038. [PubMed: 17085880].
Slater et al., 1993: Slater JD, Gibson JS, Field HJ. Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. The Journal of general virology. 1993; 74 ( Pt 5); 819-828. [PubMed: 8388018].